APA (7th ed.) Citation

Taskinen, M., Rosenstock, J., Tamminen, I., Kubiak, R., Patel, S., Dugi, K. A., & Woerle, H. (2011). Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study. Diabetes, Obesity & Metabolism, 13(1), 65. https://doi.org/10.1111/j.1463-1326.2010.01326.x

Chicago Style (17th ed.) Citation

Taskinen, M.-R, J. Rosenstock, I. Tamminen, R. Kubiak, S. Patel, K. A. Dugi, and H.-J Woerle. "Safety and Efficacy of Linagliptin as Add-on Therapy to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-blind, Placebo-controlled Study." Diabetes, Obesity & Metabolism 13, no. 1 (2011): 65. https://doi.org/10.1111/j.1463-1326.2010.01326.x.

MLA (9th ed.) Citation

Taskinen, M.-R, et al. "Safety and Efficacy of Linagliptin as Add-on Therapy to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-blind, Placebo-controlled Study." Diabetes, Obesity & Metabolism, vol. 13, no. 1, 2011, p. 65, https://doi.org/10.1111/j.1463-1326.2010.01326.x.